换一批2014年第43卷19期
共12篇1. Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs. 6750-64页
作者：Hyunbum,Jang； Fernando Teran,Arce； Srinivasan,Ramachandran； Bruce L,Kagan； Ratnesh,Lal； Ruth,Nussinov
2. Biological metals and metal-targeting compounds in major neurodegenerative diseases. 6727-49页
作者：Kevin J,Barnham； Ashley I,Bush
3. BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease. 6765-813页
作者：Arun K,Ghosh； Heather L,Osswald
4. Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids. 6859-69页
作者：Rebecca A,Kohnz； Daniel K,Nomura
5. PET/SPECT imaging agents for neurodegenerative diseases. 6683-91页
作者：Lin,Zhu； Karl,Ploessl； Hank F,Kung
6. Molecular medicine and neurodegenerative diseases. 6668-71页
作者：Christopher J,Chang； Benjamin F,Cravatt； Douglas S,Johnson； Mi Hee,Lim
7. P7C3 and an unbiased approach to drug discovery for neurodegenerative diseases. 6716-26页
作者：Andrew A,Pieper； Steven L,McKnight； Joseph M,Ready
8. Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease. 6692-700页
作者：Samuel A,Kotler； Patrick,Walsh； Jeffrey R,Brender； Ayyalusamy,Ramamoorthy
9. Cholesterol and metal ions in Alzheimer's disease. 6672-82页
作者：Hyuck Jin,Lee； Kyle J,Korshavn； Akiko,Kochi； Jeffrey S,Derrick； Mi Hee,Lim
10. Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer's disease. 6701-15页
作者：David J,Hayne； SinChun,Lim； Paul S,Donnelly
